Czechia, March 12 -- Czechia based Gilead Sciences s.r.o. has secured contract from Fakultni Thomayerova nemocnice for Antivirals for systemic use Drug supplies Active substance remdesivir ATC J05AB16. The value of the contract is worth 5086608000 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....